Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 8 December 2015, 22:30 HKT/SGT
Share:
    

Source: Lubrizol
Lubrizol LifeSciences Announces $15 Million Vesta Investment

CLEVELAND, Ohio, Dec 8, 2015 - (ACN Newswire) - The Lubrizol Corporation's LifeSciences business is investing $15 million to expand its global manufacturing facilities, positioning LifeSciences to better serve the growing market for medical device contract manufacturing. Since 2014, Lubrizol LifeSciences has solidified its presence in the life sciences market by introducing new products and making strategic acquisitions. This capital investment will expand multiple facilities and increase Lubrizol LifeSciences' in-house engineering capacity for both silicone and thermoplastic products.

"We have significantly enhanced our capabilities through the combination of strong polymer technology, application know-how and world-class component manufacturing," states Deb Langer, vice president and general manager, Lubrizol LifeSciences. "As healthcare companies look for total solution providers, we continue to invest in the right areas to provide valuable offerings to our customers."

Vesta, Inc., acquired by Lubrizol in August of 2014, is a leading contract manufacturer for the global medical device industry. With the addition of Vesta, Lubrizol LifeSciences now offers disposable and implantable silicone medical components and assemblies across a wide product portfolio, as well as precision thermoplastic extruded tubing. The recent acquisition of Particle Sciences, Inc., a leading contract drug development and manufacturing organization, has positioned Lubrizol LifeSciences as one of the most comprehensive drug delivery device solution providers, offering end-to-end solutions in the healthcare market.

"When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process," states Robert Miller, global business director, medical devices. "With a long history of polymer expertise and significant investment, Lubrizol LifeSciences is positioned to offer full-service development for next generation medical and pharmaceutical innovations."

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care and personal care products and pharmaceuticals, and specialty materials, including plastics technology and performance coatings in the form of specialty resins and additives. Our products for the oilfield market include technologies for exploration, production and transportation.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 9,000 employees worldwide. Revenues for 2014 were $7 billion. For more information, visit Lubrizol.com.

Media Contact
Ben Patti
+1-216-447-5827
www.lubrizol.com/LifeSciences
www.vestainc.com

###

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire


Topic: Press release summary
Source: Lubrizol


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Lubrizol
June 18, 2019 16:30 HKT/SGT
Lubrizol Announces Global Collaboration with Corbion
May 29, 2019 10:00 HKT/SGT
Particle Sciences Expands Controlled Substance Capabilities with Approval of DEA Schedule I Registration
May 29, 2019 10:00 HKT/SGT
Lubrizol to Present at the 29th CIMAC World Congress 2019
May 17, 2019 08:00 HKT/SGT
Lubrizol Aims at Circular Economy with TPU Solutions for Footwear
May 15, 2019 09:00 HKT/SGT
Lubrizol Announces Collaboration with Ultimaker's Material Alliance Program
Apr 30, 2019 08:00 HKT/SGT
Ground Breaking Ceremony at New Lubrizol LUCANT Plant
Apr 23, 2019 23:00 HKT/SGT
Lubrizol's Diamond Dispersions Business Wins Queen's Award for International Trade
Apr 18, 2019 07:30 HKT/SGT
Lubrizol to Feature New Bio TPU Grades for 3D Printing and Molded Parts at Plastteknik Fair 2019
Apr 16, 2019 07:00 HKT/SGT
Lubrizol is Ready for ILSAC GF-6 - Announcing Lubrizol(R) PV1510 Additive Technology for the GF-6 Specification
Apr 12, 2019 20:30 HKT/SGT
Lubrizol Showcases Renewable-Sourced Estane(R) 3D ECO TPU for 3D Printing at RAPID + TCT 2019
More news >>
 News Alerts
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: